Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaron Vinik

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Cell Metabolism|April 26, 2024
TM7SF3 controls TEAD1 splicing to prevent MASH-induced liver fibrosisRoi Isaac, Gautam Bandyopadhyay, Theresa V Rohm, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 8, 2021
Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug ResistanceFabienne Lamballe, Fahmida Ahmad, Yaron Vinik, et al.
Cell Death & Disease|November 28, 2025
Dissecting endometrial cancer complexity in response to standard and targeted therapiesSebastiano Vaccarella, Valentina Bruno, Giulia Orlandi, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
<i>TMPRSS2-ERG</i> confers resistance to antiandrogens: mechanism and therapeutic implicationsArunachalam Sekar, Rishita Chatterjee, Boobash Raj Selvadurai, et al.
EMBO Molecular Medicine|May 12, 2026
TMPRSS2-ERG confers resistance of prostate cancer to antiandrogensArunachalam Sekar, Boobash Raj Selvadurai, Rishita Chatterjee, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Cell Metabolism|April 26, 2024
TM7SF3 controls TEAD1 splicing to prevent MASH-induced liver fibrosisRoi Isaac, Gautam Bandyopadhyay, Theresa V Rohm, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 8, 2021
Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug ResistanceFabienne Lamballe, Fahmida Ahmad, Yaron Vinik, et al.
Cell Death & Disease|November 28, 2025
Dissecting endometrial cancer complexity in response to standard and targeted therapiesSebastiano Vaccarella, Valentina Bruno, Giulia Orlandi, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
<i>TMPRSS2-ERG</i> confers resistance to antiandrogens: mechanism and therapeutic implicationsArunachalam Sekar, Rishita Chatterjee, Boobash Raj Selvadurai, et al.
EMBO Molecular Medicine|May 12, 2026
TMPRSS2-ERG confers resistance of prostate cancer to antiandrogensArunachalam Sekar, Boobash Raj Selvadurai, Rishita Chatterjee, et al.
Pageof 3